China Pharma Holdings (CPHI) Change in Account Payables (2010 - 2026)

China Pharma Holdings (CPHI) has reported Change in Account Payables for 17 consecutive years, with -$115563.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Account Payables fell 498.09% year-over-year to -$115563.0; the trailing twelve-month figure through Jun 2026 stood at $163362.0 (down 58.28% YoY), and the FY2025 full-year result was $650309.0, up 188.61% from the prior year.
• Change in Account Payables slipped to -$115563.0 in Q2 2026 per CPHI's latest filing, from -$67771.0 in the prior quarter.
• Across five years, Change in Account Payables topped out at $442807.0 in Q3 2023 and bottomed at -$505339.0 in Q2 2024.
• Historically, Change in Account Payables has averaged -$7923.9 across 5 years, with a median of $25512.0 in 2022.
• The sharpest annual moves came in 2023 and 2026: Change in Account Payables soared 3045.77% in 2023, then tumbled 498.09% in 2026.
• Over 5 years, Change in Account Payables stood at $238485.0 in 2022, then plunged by 54.75% to $107922.0 in 2023, then plunged by 244.32% to -$155753.0 in 2024, then soared by 287.64% to $292259.0 in 2025, then tumbled by 139.54% to -$115563.0 in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$115563.0, -$67771.0, and $292259.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.